Ranbaxy Laboratories Gains in Mumbai After U.S. Withdraws Motion

Oct. 8 (Bloomberg) -- Ranbaxy Laboratories Ltd., the Indian drugmaker being purchased by Japan's Daiichi Sankyo Co., rose the most in almost three months after the U.S. withdrew a motion seeking to force the company to turn over audit reports.